vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Life360, Inc. (LIF). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $146.0M, roughly 1.2× Life360, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 26.4%). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
ESPR vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $146.0M |
| Net Profit | — | $129.7M |
| Gross Margin | — | 75.1% |
| Operating Margin | 50.6% | 6.1% |
| Net Margin | — | 88.8% |
| Revenue YoY | 143.7% | 26.4% |
| Net Profit YoY | — | 1425.9% |
| EPS (diluted) | $0.32 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $146.0M | ||
| Q3 25 | $87.3M | $124.5M | ||
| Q2 25 | $82.4M | $115.4M | ||
| Q1 25 | $65.0M | $103.6M | ||
| Q4 24 | $69.1M | $115.5M | ||
| Q3 24 | $51.6M | $92.9M | ||
| Q2 24 | $73.8M | $84.9M | ||
| Q1 24 | $137.7M | $78.2M |
| Q4 25 | — | $129.7M | ||
| Q3 25 | $-31.3M | $9.8M | ||
| Q2 25 | $-12.7M | $7.0M | ||
| Q1 25 | $-40.5M | $4.4M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $-29.5M | $7.7M | ||
| Q2 24 | $-61.9M | $-11.0M | ||
| Q1 24 | $61.0M | $-9.8M |
| Q4 25 | — | 75.1% | ||
| Q3 25 | — | 78.0% | ||
| Q2 25 | — | 78.4% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 75.0% | ||
| Q1 24 | — | 76.7% |
| Q4 25 | 50.6% | 6.1% | ||
| Q3 25 | -11.4% | 4.6% | ||
| Q2 25 | 8.6% | 1.7% | ||
| Q1 25 | -34.0% | 2.1% | ||
| Q4 24 | -6.4% | 4.9% | ||
| Q3 24 | -31.0% | -5.3% | ||
| Q2 24 | 3.5% | -2.8% | ||
| Q1 24 | 52.5% | -8.2% |
| Q4 25 | — | 88.8% | ||
| Q3 25 | -35.9% | 7.9% | ||
| Q2 25 | -15.4% | 6.1% | ||
| Q1 25 | -62.2% | 4.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -57.2% | 8.3% | ||
| Q2 24 | -83.9% | -12.9% | ||
| Q1 24 | 44.3% | -12.5% |
| Q4 25 | $0.32 | $1.53 | ||
| Q3 25 | $-0.16 | $0.11 | ||
| Q2 25 | $-0.06 | $0.08 | ||
| Q1 25 | $-0.21 | $0.05 | ||
| Q4 24 | $-0.14 | $0.14 | ||
| Q3 24 | $-0.15 | $0.09 | ||
| Q2 24 | $-0.33 | $-0.15 | ||
| Q1 24 | $0.34 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $548.2M |
| Total Assets | $465.9M | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $494.3M | ||
| Q3 25 | $92.4M | $455.7M | ||
| Q2 25 | $86.1M | $432.7M | ||
| Q1 25 | $114.6M | $168.9M | ||
| Q4 24 | $144.8M | $159.2M | ||
| Q3 24 | $144.7M | $159.0M | ||
| Q2 24 | $189.3M | $160.8M | ||
| Q1 24 | $226.6M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $-302.0M | $548.2M | ||
| Q3 25 | $-451.4M | $391.4M | ||
| Q2 25 | $-433.5M | $366.7M | ||
| Q1 25 | $-426.2M | $376.3M | ||
| Q4 24 | $-388.7M | $358.5M | ||
| Q3 24 | $-370.2M | $339.7M | ||
| Q2 24 | $-344.2M | $326.7M | ||
| Q1 24 | $-294.3M | $239.8M |
| Q4 25 | $465.9M | $959.7M | ||
| Q3 25 | $364.0M | $787.5M | ||
| Q2 25 | $347.1M | $753.6M | ||
| Q1 25 | $324.0M | $455.4M | ||
| Q4 24 | $343.8M | $441.6M | ||
| Q3 24 | $314.1M | $427.4M | ||
| Q2 24 | $352.3M | $405.9M | ||
| Q1 24 | $373.1M | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $36.8M |
| Free Cash FlowOCF − Capex | — | $36.6M |
| FCF MarginFCF / Revenue | — | 25.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $36.8M | ||
| Q3 25 | $-4.3M | $26.4M | ||
| Q2 25 | $-31.4M | $13.3M | ||
| Q1 25 | $-22.6M | $12.1M | ||
| Q4 24 | $-35.0M | $12.3M | ||
| Q3 24 | $-35.3M | $6.3M | ||
| Q2 24 | $-7.2M | $3.3M | ||
| Q1 24 | $53.8M | $10.7M |
| Q4 25 | — | $36.6M | ||
| Q3 25 | — | $25.6M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-35.5M | $6.3M | ||
| Q2 24 | $-7.3M | $3.2M | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | 25.1% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -68.7% | 6.8% | ||
| Q2 24 | -9.9% | 3.8% | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 1.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LIF
Segment breakdown not available.
